Pharming Group News

Pharming Group Is Maintained at Outperform by Oppenheimer

Dow JonesOct 28 20:56

Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $30

Futu NewsOct 28 20:35

Pharming Analyst Ratings

BenzingaOct 25 03:14

H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37

Futu NewsOct 24 23:31

H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37

Futu NewsOct 15 18:36

Pharming Analyst Ratings

BenzingaOct 11 00:34

H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37

Futu NewsOct 10 22:32

Buy Rating Affirmed for Pharming Group on Leniolisib's Progress and Joenja's Market Expansion

TipRanksOct 10 22:17

Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $31

Futu NewsSep 27 20:31

Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)

TipRanksSep 27 19:49

H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37

Futu NewsSep 26 23:32

Pharming Analyst Ratings

BenzingaSep 26 23:00

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

BenzingaSep 26 23:00

Pharming Group's Joenja Garners Buy Rating Amid Regulatory Successes and Growth Potential

TipRanksSep 26 22:39

Oppenheimer Sticks to Its Buy Rating for Pharming Group (PHAR)

TipRanksAug 2 20:36

Oppenheimer Initiates Pharming Group(PHAR.US) With Buy Rating, Announces Target Price $31

Futu NewsAug 2 20:35

Pharming Analyst Ratings

BenzingaAug 2 04:21

HC Wainwright & Co. Reiterates Buy on Pharming, Maintains $37 Price Target

BenzingaAug 2 04:20

H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37

Futu NewsAug 1 22:32

Pharming Analyst Ratings

BenzingaMay 31 18:50